首页> 美国卫生研究院文献>Molecules >Chemical Synthesis Backbone Cyclization and Oxidative Folding of Cystine-knot Peptides — Promising Scaffolds for Applications in Drug Design
【2h】

Chemical Synthesis Backbone Cyclization and Oxidative Folding of Cystine-knot Peptides — Promising Scaffolds for Applications in Drug Design

机译:胱氨酸结肽的化学合成骨干环化和氧化折叠-有望用于药物设计的支架

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cystine-knot peptides display exceptional structural, thermal, and biological stability. Their eponymous motif consists of six cysteine residues that form three disulfide bonds, resulting in a notably rigid structural core. Since they highly tolerate either rational or combinatorial changes in their primary structure, cystine knots are considered to be promising frameworks for the development of peptide-based pharmaceuticals. Despite their relatively small size (two to three dozens amino acid residues), the chemical synthesis route is challenging since it involves critical steps such as head-to-tail cyclization and oxidative folding towards the respective bioactive isomer. Herein we describe the topology of cystine-knot peptides, their synthetic availability and briefly discuss potential applications of engineered variants in diagnostics and therapy.
机译:胱氨酸结肽显示出异常的结构,热和生物稳定性。它们的同名基序由六个半胱氨酸残基组成,这些残基形成三个二硫键,从而形成明显的刚性结构核心。由于它们高度耐受其一级结构的合理或组合变化,因此胱氨酸结被认为是开发基于肽的药物的有前途的框架。尽管它们的尺寸相对较小(2至3个氨基酸残基),但化学合成路线颇具挑战性,因为它涉及关键步骤,例如从头到尾的环化和向各自生物活性异构体的氧化折叠。在这里,我们描述了胱氨酸结肽的拓扑结构,其合成可用性,并简要讨论了工程变体在诊断和治疗中的潜在应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号